Actualités NeuroMetrix Inc - NUROW | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

NeuroMetrix Announces One-for-Ten Reverse Split

WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the...

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,827,420. The patent...

NeuroMetrix Closes $3.5 Million Equity Offering

NeuroMetrix, Inc. (NASDAQ: NURO) today closed a $3.5 million private placement of 3,500 shares of Series F convertible preferred stock at a...

NeuroMetrix Reports Q3 2017 Financial Results

Overall revenue of $3.5M is up 5% year-over-year Quell shipments of 15.6K devices are up 29% year-over-year Quell shipments of 28.7K...

NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 third quarter financial results before the opening of the...

NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Septemb...

NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting company at the 19th Annual Rodman & Renshaw Global Investment...

Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the upcoming PAINWeek national conference to...

NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain

In recognition of Pain Awareness Month this September, NeuroMetrix, Inc. (Nasdaq: NURO) is partnering with the U.S. Pain Foundation, a...

NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 9,731,126. The patent...

NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan

NeuroMetrix, Inc. (Nasdaq: NURO) today reported an agreement with Fukuda Denshi for DPNCheck® distribution in Japan. DPNCheck is...

NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015

NeuroMetrix, Inc. (Nasdaq: NURO) reported today that it had shipped its 100,000th Quell® wearable device for treatment of chronic pain since...

NeuroMetrix Reports Q2 2017 Financial Results

Revenue of $4.3M is up 63% year-over-year Quell device shipments of 20.1K and electrode reorders of 30.7K represent new quarterly...

NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call

NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2017 second quarter financial results before the opening of the...

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock

NeuroMetrix, Inc. (NASDAQ: NURO) announced today that it has entered into a definitive securities purchase agreement with a healthcare...

NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics

NeuroMetrix, Inc. (Nasdaq: NURO) today reported that Michael MacDonald has been promoted to SVP and General Manager of Diagnostics. In this...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

NeuroMetrix Inc (NUROW)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

NUROW Actualités

NeuroMetrix Announces One-for-Ten Reverse Split

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix Closes $3.5 Million Equity Offering

NeuroMetrix Reports Q3 2017 Financial Results

NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call

NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Septemb...

Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference

NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain

NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep

NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan

NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015

NeuroMetrix Reports Q2 2017 Financial Results

NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock

NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

NeuroMetrix Inc (NUROW) Actualités

NeuroMetrix Inc (NUROW)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

NUROW Actualités

NeuroMetrix Announces One-for-Ten Reverse Split

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

NeuroMetrix Closes $3.5 Million Equity Offering

NeuroMetrix Reports Q3 2017 Financial Results

NeuroMetrix, Inc. Announces Date for 2017 Third Quarter Financial Results Conference Call

NeuroMetrix Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City Septemb...

Two Studies Derived from Quell Health Cloud to be Presented at Upcoming PAINWeek National Conference

NeuroMetrix Teams Up with U.S. Pain Foundation to Raise Awareness of Chronic Pain

NeuroMetrix Announces Issuance of New U.S. Patent for Automated Control of Quell Therapy During Sleep

NeuroMetrix Announces DPNCheck Distribution Agreement with Fukuda Denshi in Japan

NeuroMetrix Announces Shipment of 100,000th Quell Device Since Launch in 2015

NeuroMetrix Reports Q2 2017 Financial Results

NeuroMetrix, Inc. Announces Date for 2017 Second Quarter Financial Results Conference Call

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock

NeuroMetrix Reports Promotion of Michael MacDonald to Senior Vice President and General Manager of Diagnostics

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités